维普中文期刊产品整合服务
9篇 您的检索式:作者名="Fortuna AM"
    题名 作者 年代 出处 被引量
1Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review显示文摘The new antiepileptic drugs perampanel,retigabine,rufinamide and stiripentol have been recently approved for different epilepsy types.Being them an innovation in the antiepileptics armamentarium,a lot of investigations regarding their pharmacological properties are yet to be performed.Besides,considering their broad anticonvulsant activities,an extension of their therapeutic indications may be worthy of investigation,especially regarding other seizure types as well as other central nervous system disorders.Although different liquid chromatographic(LC)methods coupled with ultraviolet,fluorescence,mass or tandem-mass spectrometry detection have already been developed for the determination of perampanel,retigabine,rufinamide and stiripentol,new and more cost-effective methods are yet required.Therefore,this review summarizes the main analytical aspects regarding the liquid chromatographic methods developed for the analysis of perampanel,retigabine(and its main active metabolite),rufinamide and stiripentol in biological samples and pharmaceutical dosage forms.Furthermore,the physicochemical and stability properties of the target compounds will also be addressed.Thus,this review gathers,for the first time,important background information on LC methods that have been developed and applied for the determination of perampanel,retigabine,rufinamide and stiripentol,which should be considered as a starting point if new(bio)analytical techniques are aimed to be implemented for these drugs.Sara Meirinho Marcio Rodrigues Ana Fortuna Amílcar Falcao Gilberto Alves 2021Journal of Pharmaceutical Analysis2021,11,4:2
2Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome 显示文摘Fortuna AM Miralda R Calaf N 2011Respir Med2011,105,:1
3Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome 显示文摘Fortuna AM Miralda R Calaf N 2011Respir Med2011,105,4:1
4Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome显示文摘Fortuna AM Miralda Rv Calaf N 2011Respir Med2011,105,4:1
5Dominant mutations in ROR2,encoding an orphan receptor tyrosine kinase,cause brachydactyly type B显示文摘Oldridge M Fortuna AM Maringa M 2000Nat Genet2000,24,3:1
6Diagnostic ulility of inflammatory biomarkers in asthma: Exhaled nitric oxide and induced sputum eosinophil count 显示文摘Fortuna AM Feixas T Gonzalez M 2007Respir Med2007,101,11:1
7Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B 显示文摘Oldridge M Fortuna AM Maringa M Propping P Man- sour S Pollitt C DeChiara TM Kimble RB Valenzuela DM Yancopoulos GD Wilkie AO 2000Nat Genet2000,24,3:1
8Dominant mutations in ROR2,encoding an orphan receptor tyrosine kinase,cause brachydactyly type B显示文摘Oldridge M Fortuna AM Maringa M 2000Nat Genet2000,24,3:1
9Obstructive sleep apnoea and metabolic impairment in severe obesity显示文摘Gasa M Salord N Fortuna AM 2011Eur Respir J2011,38,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费